Alternatives to Gilead Sciences

Developing engineered biologics to harness the immune system for disease treatment.

Biotechnology company developing novel immunotherapies for cancer.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Biotech company developing novel therapeutics for regenerative medicine and oncology.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Immunotherapy company targeting oncology and autoimmune diseases.

Biotechnology company developing cell and gene therapies for serious diseases.

Biopharmaceutical company focused on developing orally administered therapeutics for inflammatory disorders and cancer.

Developing transformative fusion immunotherapeutics for autoimmune diseases, cancer, and senescence-associated dysplasia.

Developing immunotherapeutic bi-functional fusion proteins to harness the immune system against cancer.

A global oncology company developing and commercializing innovative cancer treatments.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.